Category:

Diversity in Clinical Trials: The Latest FDA Guidance

Feb 21st, 2024 in
Diversity in Clinical Trials: The Latest FDA Guidance
Diversity has always mattered in clinical trials. As the National Institutes of Health (NIH) notes, “people may experience the same disease differently.” With a more diverse pool of clinical trial participants, researchers can better account for these differences and support medical advancements that benefit the broader population. For almost 10 years, diversity in clinical trials […]
Continue reading »

Why Is It So Hard To Find Healthy Volunteers for Clinical Trials?

Jan 23rd, 2024 in
Why Is It So Hard To Find Healthy Volunteers for Clinical Trials?
Healthy volunteers are a cornerstone of successful clinical trials. Before medications or devices are given to patient groups with a specific condition, interventions on healthy volunteers set a baseline in the early stages of clinical research. These control groups ultimately pave the way for innovative treatments. While the value of healthy volunteers in clinical trials […]
Continue reading »

Trends in Immunology Clinical Trials: An Interview With Dr. Ian Baird

Jan 17th, 2024 in
Trends in Immunology Clinical Trials: An Interview With Dr. Ian Baird
The landscape of immunology clinical trials rarely stands still, from breakthroughs in scientific advancements to changing outlooks on trial dynamics and expectations. Dr. Ian Baird, a Remington-Davis (RDI) board-certified infectious disease physician who has conducted 262 trials over the last 37 years, shared his thoughts on recent trends in clinical trials that are shaping this […]
Continue reading »

Two OSU nursing students take part in clinical trials that might help battle COVID-19

Jul 31st, 2020 in
Here’s your chance to catch up on a story featuring two #OSUNursing students who #volunteered for a #clinicaltrial with #RemingtonDavis when they contracted #Covid_19. by: Shawn Lanier Posted: Jul 31, 2020 / 05:57 PM EDT  Updated: Jul 31, 2020 / 06:00 PM EDT “If she hadn’t gotten it, I never would have known,” said Boldt.  She did not have any symptoms but Campanelli did.  “I only had […]
Continue reading »

Remington-Davis launches dedicated COVID-19 research unit in Ohio

Jul 08th, 2020 in
Remington-Davis launches dedicated COVID-19 research unit in Ohio
By Chris Newmarker | July 8, 2020 Clinical research outfit Remington-Davis recently announced that it has launched a dedicated 3,000 ft2 space in Columbus, Ohio for COVID-19 clinical trials. The space includes six private overnight rooms, patient lounge, dedicated laboratory, oxygen therapy and more. Participants must be 18 or older with COVID-19 symptoms and have a laboratory-confirmed SARS-CoV2 infection. “We were […]
Continue reading »